The association of body mass index and prostate-specific antigen in a population-based study.

@article{Baillargeon2005TheAO,
  title={The association of body mass index and prostate-specific antigen in a population-based study.},
  author={Jacques G. Baillargeon and Brad H Pollock and Alan Kristal and Patrick Bradshaw and J. Vergara Hern{\'a}ndez and Joseph Basler and Betsy Higgins and Steve Lynch and Thomas A. Rozanski and Dean Troyer and Ian S. Thompson},
  journal={Cancer},
  year={2005},
  volume={103 5},
  pages={1092-5}
}
BACKGROUND Recent studies of men with prostate carcinoma suggest that obesity may be associated with more advanced-stage disease and lower overall survival rates. One possible link between body mass index (BMI) and prostate carcinoma prognosis may be disease ascertainment. Prostate-specific antigen (PSA) is widely used to screen for prostate carcinoma. METHODS The authors examined the association between BMI and PSA in a population-based study of 2779 men without prostate carcinoma. Between… CONTINUE READING